What is H.C. Wainwright's price target for SRTS?

H.C. Wainwright's latest stated price target for Sensus Healthcare Inc. (SRTS) is $13, from its action on Mar 3, 2022.

What is H.C. Wainwright's rating on SRTS?

H.C. Wainwright rates SRTS Buy, a bullish rating, as of Mar 3, 2022.

When did H.C. Wainwright last change its view on SRTS?

On Mar 3, 2022, H.C. Wainwright raises its price target to $13 from $12, keeps Buy.

H.C. Wainwright SRTS price target and rating history

Sensus Healthcare Inc. (SRTS) · Health Care

H.C. Wainwright rates Sensus Healthcare Inc. (SRTS) Buy with a $13 price target, as of its latest action on Mar 3, 2022. It has published 5 rating actions on SRTS since August 2021, including 0 upgrades and 0 downgrades.

Current rating: Buy
Price target: $13
Median target, all firms: Too few
Actions on SRTS: 5

H.C. Wainwright price target on SRTS

H.C. Wainwright price target on SRTS, each point a stated target, August 2021 to March 2022.

Every H.C. Wainwright rating on SRTS

Mar 3, 2022
ReiterateH.C. Wainwright raises its price target to $13 from $12, keeps Buy
Feb 14, 2022
ReiterateH.C. Wainwright raises its price target to $12 from $10, keeps Buy
Dec 2, 2021
ReiterateH.C. Wainwright raises its price target to $10 from $9, keeps Buy
Nov 5, 2021
ReiterateH.C. Wainwright raises its price target to $9 from $7, keeps Buy
Aug 6, 2021
ReiterateH.C. Wainwright raises its price target to $7 from $6, keeps Buy

Questions about H.C. Wainwright and SRTS

What is H.C. Wainwright's price target for SRTS?: H.C. Wainwright's latest stated price target for Sensus Healthcare Inc. (SRTS) is $13, from its action on Mar 3, 2022.
What is H.C. Wainwright's rating on SRTS?: H.C. Wainwright rates SRTS Buy, a bullish rating, as of Mar 3, 2022.
When did H.C. Wainwright last change its view on SRTS?: On Mar 3, 2022, H.C. Wainwright raises its price target to $13 from $12, keeps Buy.

All H.C. Wainwright ratings SRTS news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.